Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

30 trials with published results (9%)

Research Maturity

174 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

15 terminated out of 345 trials

Success Rate

92.1%

+5.6% vs benchmark

Late-Stage Pipeline

14%

49 trials in Phase 3/4

Results Transparency

17%

30 of 174 completed with results

Key Signals

30 with results92% success15 terminated

Data Visualizations

Phase Distribution

224Total
Not Applicable (138)
Early P 1 (4)
P 1 (4)
P 2 (29)
P 3 (30)
P 4 (19)

Trial Status

Completed174
Recruiting60
Unknown54
Active Not Recruiting19
Terminated15
Not Yet Recruiting12

Trial Success Rate

92.1%

Benchmark: 86.5%

Based on 174 completed trials

Clinical Trials (345)

Showing 20 of 20 trials
NCT07185022Not ApplicableRecruiting

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

NCT04036409Not ApplicableActive Not Recruiting

Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

NCT06615973Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT05326230Not ApplicableActive Not Recruiting

A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

NCT03626688Phase 3Completed

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT06907147Not ApplicableRecruiting

SPYRAL GEMINI Pilot Study

NCT07013929Not ApplicableRecruiting

Spyral InSight Study

NCT06297291Recruiting

Global Paradise System US Post Approval Study

NCT06271577Not ApplicableRecruiting

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

NCT07115953Not ApplicableRecruiting

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

NCT00009243Recruiting

Natural History of Stroke: Cause and Development

NCT03037411Completed

A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

NCT03947905Not ApplicableWithdrawnPrimary

Virtual and Physical Health Assessments and Treatment Plans

NCT04584632Not ApplicableRecruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

NCT05198674Not ApplicableActive Not Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT07214376Not ApplicableNot Yet Recruiting

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT07449325Not ApplicableNot Yet Recruiting

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

NCT04390672Not ApplicableActive Not Recruiting

Multivessel TALENT

NCT07174622Recruiting

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

NCT07427108Not ApplicableRecruiting

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

Scroll to load more

Research Network

Activity Timeline